Chiron Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Sell |
286,413
-13,195
| -4% | -$611K | 11.54% | 1 |
|
|
2025
Q1 | $18.3M | Sell |
299,608
-109,920
| -27% | -$6.7M | 16.61% | 1 |
|
|
2024
Q4 | $23.2M | Sell |
409,528
-35,078
| -8% | -$1.98M | 21.86% | 1 |
|
|
2024
Q3 | $23M | Sell |
444,606
-7,778
| -2% | -$402K | 20.36% | 1 |
|
|
2024
Q2 | $18.8M | Buy |
452,384
+5,664
| +1% | +$235K | 17.94% | 1 |
|
|
2024
Q1 | $24.2M | Buy |
446,720
+2,105
| +0.5% | +$114K | 22% | 1 |
|
|
2023
Q4 | $22.8M | Sell |
444,615
-25,095
| -5% | -$1.29M | 19.85% | 1 |
|
|
2023
Q3 | $27.3M | Sell |
469,710
-8,963
| -2% | -$520K | 23.45% | 1 |
|
|
2023
Q2 | $30.6M | Buy |
478,673
+1,538
| +0.3% | +$98.4K | 24.24% | 1 |
|
|
2023
Q1 | $33.1M | Sell |
477,135
-9,013
| -2% | -$625K | 22.99% | 1 |
|
|
2022
Q4 | $35M | Sell |
486,148
-35,991
| -7% | -$2.59M | 24.33% | 1 |
|
|
2022
Q3 | $37.1M | Sell |
522,139
-15,058
| -3% | -$1.07M | 24.94% | 1 |
|
|
2022
Q2 | $41.4M | Sell |
537,197
-80,823
| -13% | -$6.22M | 26.09% | 1 |
|
|
2022
Q1 | $45.1M | Sell |
618,020
-95,696
| -13% | -$6.99M | 28.45% | 1 |
|
|
2021
Q4 | $44.5M | Sell |
713,716
-370
| -0.1% | -$23.1K | 32.12% | 1 |
|
|
2021
Q3 | $42.3M | Buy |
714,086
+50,004
| +8% | +$2.96M | 30.82% | 1 |
|
|
2021
Q2 | $44.4M | Sell |
664,082
-100,971
| -13% | -$6.75M | 36.97% | 1 |
|
|
2021
Q1 | $48.3M | Sell |
765,053
-7,414
| -1% | -$468K | 40.99% | 1 |
|
|
2020
Q4 | $47.9M | Sell |
772,467
-11,612
| -1% | -$720K | 39.45% | 1 |
|
|
2020
Q3 | $47.3M | Buy |
+784,079
| New | +$47.3M | 38.07% | 1 |
|